Email updates

Keep up to date with the latest news and content from Retrovirology and BioMed Central.

This article is part of the supplement: 15th International Conference on Human Retroviruses: HTLV and Related Viruses

Open Access Meeting abstract

Potential interference of HTLV-1 HBZ protein with the DNA damage response pathway

Torsten Wurm* and Isabelle Lemasson

Author Affiliations

Department of Microbiology and Immunology, East Carolina University, Greenville, NC, 27834, USA

For all author emails, please log on.

Retrovirology 2011, 8(Suppl 1):A203  doi:10.1186/1742-4690-8-S1-A203


The electronic version of this article is the complete one and can be found online at: http://www.retrovirology.com/content/8/S1/A203


Published:6 June 2011

© 2011 Wurm and Lemasson; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Meeting abstract

It takes decades after infection by HTLV-1 for an individual to develop adult T-cell leukemia/lymphoma. This disease is associated with increase genomic instability, due to an alteration of the DNA damage response of the infected cells. While this alteration has been attributed to the viral protein Tax, we found that the viral protein HBZ might also play a role in this process. In this study, we found that expression of HBZ in Jurkat cells increases the sensitivity of these cells to Etoposide treatment. Etoposide phosphate is an anticancer drug that induces DNA damage. This drug acts by forming a ternary complex with DNA and Topoisomerase II, leading to inhibition of the enzyme and creating double strand breaks. As a result, errors are incorporated into the DNA and the cells undergo apoptosis. We treated a stable cell line expressing HBZ, or the backbone vector, with 12.5μM Etoposide for 24 hrs. To determine the percentage of viable cells as well as cells in early or late apoptosis, we used a combination of Propidium iodide and Annexin V staining. Interestingly, we found that the cells expressing HBZ exhibit a 16% increase in total apoptotic cells and a13 % increase in late apoptotic cells compared to the cells expressing the backbone vector. This result suggests that HBZ increases DNA damage following Etoposide treatment. Current and future work investigates the effect of HBZ on other activators of the DNA damage response and tries to delineate the effect of HBZ on the regulation of the DNA damage response pathway.